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Aims To determine the incidence of medically unexplained visual loss (MUVL) in children in an open 40 
access children’s eye casualty. 41 
Methods We collated demographic and clinical data of consecutive patients younger than 16 years 42 
who presented to the children’s eye casualty at Moorfields Eye Hospital over a 12-month period and 43 
were diagnosed with MUVL or suspected MUVL. We reviewed the clinical records at least three 44 
months after initial presentation. We calculated the incidence using the number of "new patient" 45 
attendances over the same period as denominator (n=2 397). We used descriptive analysis. Main 46 
outcome measures: number of patients diagnosed with MUVL, proportion of patients with a history 47 
of or present psychological problems, recovery rate, improvement in visual acuity. 48 
Results We identified 85 cases of MUVL (54 females; mean age: 9 years (IQR 7 to 12)). The median 49 
duration of follow-up was 1.2 months (IQR 0 to 4.3). The estimated annual incidence was 3.5% (95% 50 
confidence interval 2.9 to 4.4%). 33% of children had a history of psychiatric disorders, reported a 51 
stressful life event or showed signs of psychiatric disorder at the time of first presentation. The 52 
recovery rate was 25%. Median improvement in best corrected visual acuity from presentation to 53 
last appointment was 0.22 (IQR 0.06 to 0.43) logMAR. 54 
Conclusions The incidence of MUVL is higher and the rate of resolution lower than previously 55 
reported. MUVL may be associated with mental health problems. We recommend screening for 56 
psychological problems to facilitate access to psychological treatment.  57 




Medically unexplained visual loss (MUVL) describes visual loss or visual symptoms in the absence of 60 
any medically detectable eye, visual pathway or brain condition. It is classified as a conversion 61 
disorder, in DSM-5, that is, a functional neurological symptom disorder resulting in loss of function. 62 
As with other medically unexplained symptoms, there is no universally accepted definition.1 A 63 
number of different terms are used to describe the condition, and terminology has evolved over 64 
time (medically unexplained visual loss, non-organic visual loss, functional visual loss, hysterical 65 
visual loss, malingering, non-physiologic visual loss, factitious visual loss, psychogenic visual loss, 66 
hypochondriasis, and conversion disorder of vision).2-5 We will use the term medically unexplained 67 
vision loss throughout this manuscript as this is the term families have told us is most acceptable as 68 
it makes no assumptions about cause.  69 
In children, MUVL is not uncommon. The reported prevalence ranges from 1 to 9%.6-8 The incidence 70 
of MUVL has been estimated at 1 to 1.75%.9, 10 As in adults with MUVL11 and other medically 71 
unexplained symptoms 12, socio-economic factors may also contribute to MUVL in children .  72 
All previous studies indicate that girls are more commonly affected than boys.9, 13-15 The reported 73 
mean age at presentation ranges from 9.0 to 13.4 years, but younger children can also be affected.9, 74 
10, 13-18 The most common complaints are deterioration of visual acuity, visual field defects and 75 
double vision.5, 9, 14, 15 In the majority of cases both eyes are affected.9, 13-15 Other symptoms are 76 
photopsia (perception of flashes of light which are usually brief and intermittent), perception of 77 
phosphenes (light perceptions of any colour or shape other than intermittent flashes which are not 78 
induced by light entering the eye), photophobia (light hyper-sensitivity), dyschromatopsia (altered 79 
perception of colours), amblyopia, voluntary nystagmus, accommodation weakness, ptosis, 80 
blepharospasm and painful eyes.3, 5, 14, 15, 19 Some children have a history of previous eye diseases and 81 
treatment.13, 20 MUVL in the presence of known eye diseases and/or non-ocular conditions such as 82 
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asthma, autoimmune diseases and accidental13, 21 or surgical trauma is referred to as functional 83 
overlay.20   84 
Children with MUVL are more likely to also report other medically unexplained physical symptoms 85 
such as headaches and abdominal or limb pain.14 MUVL is also associated with factors similar to 86 
those underlying other medically unexplained physical symptoms. For example, 40 to 90%9, 19, 22 of 87 
children with MUVL also report psychological stressors such as family problems, problems at school 88 
or bullying.10, 19, 23 High rates of mental health problems have been reported in adults with MUVL14 , 89 
and some research has indicated that young people with MUVL are more likely to report symptoms 90 
such as depression and attention deficit hyperactivity disorder.16,25-28 As with other medically 91 
unexplained symptoms, there are likely to be multiple interacting causal factors, and the presence of 92 
comorbid mental health disorders does not suggest that symptoms are ‘all in the mind’. In other 93 
medically unexplained symptoms (e.g. headache, stomach pains etc.), as many as 30-50% of children 94 
have associated mental health disorders.24 Screening for, and detecting mental health problems in 95 
children with MUVL may facilitate access to appropriate services.2, 4, 14, 15  96 
The rate of spontaneous resolution of MUVL in children has been reported to be high, particularly in 97 
studies with long follow-up data, ranging from 37% at 12 months10 to 100%9 (unknown duration of 98 
follow-up); the management of MUVL therefore often focuses on providing reassurance to the child 99 
and family that the visual prognosis is excellent.  100 
There are no management recommendations for ophthalmologists, beyond the establishment of the 101 
diagnosis. In order to establish current practice and outcomes and to facilitate service planning and 102 
the development of future research projects we carried out a retrospective observational study to 103 
describe incidence, clinical characteristics of patients, current diagnostic workup and outcomes of 104 
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Subjects and Methods 109 
This service evaluation had Trust approval (CA16/ONSP/91). A research fellow (MCD) We collated 110 
demographic and clinical data of consecutive patients younger than 16 years who presented to the 111 
children’s eye casualty at Moorfields Eye Hospital over a 12-month period and were diagnosed with 112 
MUVL or suspected MUVL. The research fellow We reviewed clinical records at least three months 113 
after the initial presentation. All information was gathered from the clinical notes. We calculated the 114 
incidence using the number of "new patient" attendances over the same period as denominator 115 
(n=2 397). Patients were included into the study if a diagnosis of “MUVL” or “functional visual loss” 116 
was documented in the medical notes and was not revised over subsequent clinic visits.  117 
We recorded any history of previous eye problems that had occurred at least four weeks before the 118 
presentation which led to a diagnosis of MUVL and could therefore be reasonably assumed to be 119 
unrelated. Children were considered as having fully recovered if they felt the eye problems had 120 
completely resolved and visual acuity was at least 0.1 logMAR in the initially affected eye. In cases 121 
where visual acuity at first presentation could not be determined in logMAR values (“hand 122 
movements” or “perception of light”), we did not quantify the change in vision between visits. The 123 
main outcome measures were the number of patients diagnosed with MUVL, the proportion of 124 
patients with a history of or present psychological problems, the recovery rate and the improvement 125 






We identified 88 cases of suspected MUVL. Three children were subsequently found to have isolated 132 
optic disc atrophy, macular dystrophy, or optic neuropathy, confirmed by abnormal 133 
electrophysiological findings. These children were excluded from the analysis. 85 cases were 134 
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included in the analysis. We estimated the annual incidence in our setting to be 3.5% (95% 135 
confidence interval 2.85 to 4.35%). The number of children diagnosed with MUVL peaked during the 136 
winter months (Fig. 1).  137 
  138 
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Patient characteristics  139 
The median age at presentation was 9 years (IQR 7 to 12). 54 patients were girls. The median 140 
number of appointments was 2 (IQR 1 to 3). 28 children only attended once. The median time from 141 
onset of symptoms until initial presentation was 1 week (IQR 0.14 to 2); the median duration of 142 
follow-up was 1.2 months (IQR 0 to 4.3) (Table 1).  143 
 144 
Diagnostic workup and findings  145 
There was considerable variability in diagnostic investigations (Tab. 1). 31% of all children were 146 
diagnosed with orthoptic abnormalities or refractive errors, 12% showed abnormal visual field test 147 
results. 57% had a previous history of contact with eye health professionals, for glasses or surgical 148 
procedures. 149 
None of the children seen during this period were referred for psychological assessment or 150 
intervention.  151 
 152 
Patient history and presentation 153 
64% of all children had bilateral symptoms. 36% had a history of eye problems or ocular surgery. 154 
41% had glasses at first presentation. The most common complaints were deterioration of visual 155 
acuity (68%), painful eyes (24%), photopsia or perception of phosphenes (19%) and diplopia (19%). 156 
Complete loss of vision (13%), photophobia (9%), visual field loss (7%) and swollen lids (7%) were 157 
less common. 158 
Ocular symptoms were associated with non-ocular symptoms in 35% of all cases, headache being 159 
the most common complaint (93%).  160 
48% of all children had non-ocular health problems such as allergies, asthma and hypothyroidism. 161 
Rare diagnoses were complex regional pain syndrome, lactose intolerance, Marfan syndrome, 162 
migraine and thalassaemia. A brief behavioural and emotional symptom history and a history of 163 
previous clinical service use was taken as is usual in any paediatric consultation. 33% of all children 164 
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had a history of psychiatric disorders, or showed signs of psychiatric disorder at the time of first 165 
presentation. One child currently reported current clinical levels of depression (under psychiatric 166 
care), three children had a history of psychiatric problems but no longer showed symptoms at the 167 
time of presentation and 28% reported stressful live events. 24% reported recent injuries.  168 
 169 
Clinical course and resolution of symptoms  170 
At last follow-up 21 children (25%) had fully and 12 (14%) had partially recovered (resolution rate at 171 
3 months after first presentation: 13%, resolution rate after at least three months of follow-up: 172 
34%). The median improvement in best corrected visual acuity (worse affected eye) was 0.22 173 
logMAR (IQR 0.06 to 0.43). When tested for visual acuity, four children claimed not to be able to see 174 
anything or to perceive light or hand movements only; we excluded these from the analysis.  Three 175 
of these children had normal visual acuities at the last follow-up. One child did not report any 176 
clinically significant improvement of visual acuity.  177 
 178 
 179 
  180 




Our principal finding of a 3.5%  incidence of MUVL in children and young people attending a 183 
specialist ophthalmological hospital is two to three times higher than previously reported 10,11. Our 184 
study also challenges the commonly held belief that - in children - MUVL has a high rate of 185 
spontaneous resolution. We report here that three months after presentation, 87% of those children 186 
who had at least three months of follow-up still experienced vision problems.  187 
The high incidence of MUVL in this study may be explained in part by the setting, a walk-in clinic in a 188 
specialist ophthalmological hospital providing tertiary-care level workup for patients who often have 189 
not consulted their general practitioner or local optometrist before attending our service. We 190 
observed that a high proportion of children with MUVL had previous experience with eye care 191 
providers; this may have raised their awareness of the possibility of having eye problems and direct 192 
access to eye care providers. The number of children diagnosed with MUVL peaked during the 193 
winter months, indicating possible seasonal variation. However, our sample size is small and limited 194 
to one calendar year only. In addition, we did not systematically ask children about any seasonal 195 
stressors/relieving factors (e.g. school examinations/school holidays). Further research is required to 196 
establish any seasonal variation in incidence of MUVL.   197 
MUVL may have commonalities with other medically unexplained symptoms such as headaches, 198 
abdominal pain and non-epileptic seizures, including comorbidity with common mental health 199 
disorders including anxiety, depression and behavioural problems.24 Currently there is little known 200 
about the mental health of young people with MUVL and there is no routine screening, established 201 
referral pathways or guidelines for the detection and management of mental health difficulties 202 
associated with MUVL. It has been suggested that an absence of mental health disorders may be 203 
associated with faster resolution of symptoms,25 though this finding is controversial.14, 19 Though 204 
psychiatric consultation has not yet been shown to improve final visual outcome,7 patients may 205 
benefit from addressing psychological issues.13 Cognitive behavioural and whole system approaches 206 
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to the management of other medically unexplained symptoms and associated mental health 207 
difficulties are successful for the management for both adult patients and children and young 208 
people.26-30  Screening for psychiatric comorbidity in MUVL in young people, will allow early 209 
detection of emotional and behavioural problems, and facilitate access to evidence based 210 
psychological therapies. Therefore, a comprehensive multidisciplinary assessment of these children 211 
is likely to include, in addition to the ophthalmological and medical history, a mental health review, 212 
family history and social and educational history. 213 
The low rate of recovery in this study compared with other publications  (93%14 to 100%9) may in  214 
part be explained by the lack of a standardized definition of “complete resolution”, and by the 215 
relatively short follow-up in our study. Ophthalmologists are often satisfied when good vision can be 216 
demonstrated, and limit management to providing a “strong dose of reassurance” that symptoms 217 
will resolve.7-9, 13 Some discuss psychological aspects with the family and the general practitioner.15 218 
Few refer children for neuropsychological evaluation.5 In other medically unexplained conditions, 219 
the presence of an unrecognised comorbid mental health problem can impact negatively on the 220 
symptom trajectory.24, 31 In recent years there has been an emphasis on integrating mental and 221 
physical healthcare therefore it is necessary to ensure that young people with MUVL are referred to 222 
appropriate evidence based services for treatment if a psychiatric comorbidity is identified.   223 
Limitations of our work include data collection at a single site in a highly urbanised area and the 224 
relatively short follow-up duration. The present study does not allow conclusions on the long-term 225 
course of MUVL. Longitudinal studies with a longer follow-up duration could provide valuable 226 
information on the fluctuation of symptoms and the likelihood of relapses and or the simultaneous 227 
or delayed manifestation of other types of medically unexplained symptoms. However, our setting 228 
caters for a multi-ethnic urban population and we expect our findings could be replicated in similar 229 
settings.  A further limitation is the current lack of a “positive diagnosis” and a lack of consensus in 230 
terminology.  A recent qualitative study of non-epileptic seizures highlighted the importance of 231 
families and young people having ownership over the terminology used to describe their 232 
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condition,32, 33 and the field is likely to be advanced through qualitative studies to explore and 233 
examine the experiences of young people with MUVL.  234 
To achieve optimum and rapid recovery in paediatric MUVL it is likely that integrated 235 
ophthalmological and mental health assessment and treatment will be needed.  The low rate of full 236 
recovery of MUVL with ophthalmological approaches alone, suggests that additional interventions 237 
may be needed. Identifying, understanding and alleviating psychosocial stressors may be important 238 
as they may be precipitants or causes of MUVL. In addition, establishing rates of psychiatric 239 
comorbidity (for example anxiety, depression etc) in these children will improve understanding of 240 
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Table 1. Incidence, clinical work-up and demographical and clinical characteristics of children 357 
diagnosed with MUVL. 358 
 359 
Figure 1. Seasonal variation of the number of children diagnosed with MUVL. Peak in the winter 360 
months. 361 
